small makes large molecules more powerful

Direct nanoforming of biologics is a promising new approach to allow more life-changing large-molecule drugs to reach the market, which was a key driving force behind the development of our proprietary biological technology.

Most biologics are administered intravenously, following multiple and sometimes lengthy infusion treatment schedules. We believe that our unique nanoparticles could enable alternative parenteral administration routes for more patient friendly and convenient approaches. Alternative delivery could be intranasal via nasal sprays, pulmonary, or subcutaneous injections. In these routes of administration, higher load of the nanoformed active ingredient could be possible and open up the potential for long-acting delivery of the material. Oral administration is also an exciting area for delivery of biologics and one in which nanoformed particles may have a role to play.